Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
1.130
-0.010 (-0.87%)
Jun 3, 2026, 9:35 AM EDT - Market open
Alzamend Neuro Market Cap
Alzamend Neuro has a market cap or net worth of $4.3 million as of June 3, 2026. Its market cap has increased by 57.89% in one year.
Market Cap
4.30M
Enterprise Value
1.62M
1-Year Change
57.89%
Ranking
Category
Stock Price
$1.13
Market Cap Chart
Since the IPO on June 15, 2021, Alzamend Neuro's market cap has decreased from $1.15B to $4.30M, a decrease of -99.62%. That is a compound annual growth rate of -67.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 4.34M | -37.31% |
| Dec 31, 2025 | 6.92M | 9.79% |
| Dec 31, 2024 | 6.30M | -0.56% |
| Dec 29, 2023 | 6.34M | -88.37% |
| Dec 30, 2022 | 54.47M | -67.73% |
| Dec 31, 2021 | 168.82M | -85.28% |
| Jun 15, 2021 | 1.15B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silo Pharma | 5.41M |
| Dermata Therapeutics | 5.39M |
| TransCode Therapeutics | 5.16M |
| Pulmatrix | 5.08M |
| Galmed Pharmaceuticals | 4.79M |
| Decoy Therapeutics | 4.45M |
| CDT Equity | 4.35M |
| Revelation Biosciences | 4.26M |